Rxsight Net Income From Continuing Ops vs Income Tax Expense Analysis

RXST Stock

USD 29.81 2.06 6.46%

Rxsight financial indicator trend analysis is much more than just breaking down Rxsight prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Rxsight is a good investment. Please check the relationship between Rxsight Net Income From Continuing Ops and its Income Tax Expense accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rxsight. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.

Net Income From Continuing Ops vs Income Tax Expense

Net Income From Continuing Ops vs Income Tax Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Rxsight Net Income From Continuing Ops account and Income Tax Expense. At this time, the significance of the direction appears to have weak relationship.

The correlation between Rxsight's Net Income From Continuing Ops and Income Tax Expense is 0.32. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of Rxsight, assuming nothing else is changed. The correlation between historical values of Rxsight's Net Income From Continuing Ops and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of Rxsight are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Net Income From Continuing Ops i.e., Rxsight's Net Income From Continuing Ops and Income Tax Expense go up and down completely randomly.

Correlation Coefficient

0.32

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Net Income From Continuing Ops

Income Tax Expense

Most indicators from Rxsight's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Rxsight current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rxsight. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.At this time, Rxsight's Tax Provision is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 1.3 B in 2025, whereas Selling General Administrative is likely to drop slightly above 43.3 M in 2025.

	2022	2023	2024	2025 (projected)
Depreciation And Amortization	4.0M	4.2M	4.9M	4.4M
Interest Income	1.5M	6.6M	7.6M	7.9M

Depreciation And Amortization Interest Income

Rxsight fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity
Total Assets		0.26	0.77	0.85	0.95	-0.81	0.94	-0.92	0.81	0.12	-0.83	0.68	0.61	-0.92	0.27	0.72	0.98	0.82	-0.93	0.77	0.99	-0.94	-0.86	0.82	0.84	0.94
Short Long Term Debt Total	0.26		0.09	0.14	0.33	-0.49	0.41	-0.24	-0.04	0.97	-0.2	-0.35	0.72	-0.22	0.55	-0.06	0.33	-0.02	-0.3	-0.27	0.24	-0.36	0.18	0.07	0.53	0.29
Other Current Liab	0.77	0.09		0.98	0.78	-0.85	0.74	-0.87	0.88	0.04	-0.84	0.75	0.26	-0.89	0.32	0.73	0.63	0.89	-0.67	0.89	0.66	-0.79	-0.84	0.96	0.38	0.79
Total Current Liabilities	0.85	0.14	0.98		0.86	-0.85	0.83	-0.93	0.91	0.08	-0.9	0.81	0.29	-0.93	0.43	0.84	0.72	0.91	-0.8	0.88	0.76	-0.87	-0.9	0.99	0.47	0.87
Total Stockholder Equity	0.95	0.33	0.78	0.86		-0.89	0.99	-0.98	0.89	0.22	-0.94	0.6	0.63	-0.97	0.47	0.7	0.92	0.9	-0.97	0.69	0.91	-1.0	-0.83	0.83	0.8	1.0
Other Liab	-0.81	-0.49	-0.85	-0.85	-0.89		-0.88	0.9	-0.8	-0.39	0.84	-0.4	-0.7	0.91	-0.44	-0.49	-0.76	-0.82	0.77	-0.63	-0.73	0.9	0.65	-0.79	-0.68	-0.88
Net Tangible Assets	0.94	0.41	0.74	0.83	0.99	-0.88		-0.96	0.84	0.3	-0.92	0.56	0.66	-0.95	0.51	0.69	0.92	0.85	-0.98	0.63	0.91	-1.0	-0.79	0.8	0.82	0.99
Property Plant And Equipment Net	-0.92	-0.24	-0.87	-0.93	-0.98	0.9	-0.96		-0.95	-0.15	0.96	-0.69	-0.51	1.0	-0.49	-0.77	-0.85	-0.95	0.93	-0.79	-0.86	0.98	0.88	-0.91	-0.67	-0.99
Current Deferred Revenue	0.81	-0.04	0.88	0.91	0.89	-0.8	0.84	-0.95		-0.11	-0.93	0.76	0.3	-0.95	0.39	0.75	0.71	1.0	-0.83	0.85	0.74	-0.88	-0.92	0.9	0.47	0.91
Net Debt	0.12	0.97	0.04	0.08	0.22	-0.39	0.3	-0.15	-0.11		-0.14	-0.38	0.56	-0.12	0.65	-0.06	0.17	-0.1	-0.2	-0.35	0.09	-0.25	0.26	0.04	0.35	0.18
Retained Earnings	-0.83	-0.2	-0.84	-0.9	-0.94	0.84	-0.92	0.96	-0.93	-0.14		-0.67	-0.41	0.95	-0.54	-0.75	-0.75	-0.93	0.91	-0.71	-0.77	0.95	0.86	-0.89	-0.57	-0.95
Accounts Payable	0.68	-0.35	0.75	0.81	0.6	-0.4	0.56	-0.69	0.76	-0.38	-0.67		-0.16	-0.69	0.17	0.93	0.55	0.74	-0.63	0.9	0.64	-0.6	-0.93	0.86	0.21	0.63
Cash	0.61	0.72	0.26	0.29	0.63	-0.7	0.66	-0.51	0.3	0.56	-0.41	-0.16		-0.52	0.16	-0.04	0.72	0.33	-0.55	0.09	0.62	-0.62	-0.16	0.19	0.89	0.59
Non Current Assets Total	-0.92	-0.22	-0.89	-0.93	-0.97	0.91	-0.95	1.0	-0.95	-0.12	0.95	-0.69	-0.52		-0.44	-0.74	-0.85	-0.96	0.92	-0.81	-0.86	0.97	0.89	-0.91	-0.67	-0.98
Non Currrent Assets Other	0.27	0.55	0.32	0.43	0.47	-0.44	0.51	-0.49	0.39	0.65	-0.54	0.17	0.16	-0.44		0.5	0.22	0.36	-0.52	0.04	0.21	-0.5	-0.23	0.46	0.16	0.49
Other Assets	0.72	-0.06	0.73	0.84	0.7	-0.49	0.69	-0.77	0.75	-0.06	-0.75	0.93	-0.04	-0.74	0.5		0.61	0.73	-0.76	0.77	0.69	-0.71	-0.88	0.89	0.31	0.72
Cash And Short Term Investments	0.98	0.33	0.63	0.72	0.92	-0.76	0.92	-0.85	0.71	0.17	-0.75	0.55	0.72	-0.85	0.22	0.61		0.72	-0.91	0.64	0.99	-0.9	-0.76	0.69	0.93	0.9
Net Receivables	0.82	-0.02	0.89	0.91	0.9	-0.82	0.85	-0.95	1.0	-0.1	-0.93	0.74	0.33	-0.96	0.36	0.73	0.72		-0.83	0.86	0.75	-0.89	-0.91	0.9	0.5	0.92
Common Stock Total Equity	-0.93	-0.3	-0.67	-0.8	-0.97	0.77	-0.98	0.93	-0.83	-0.2	0.91	-0.63	-0.55	0.92	-0.52	-0.76	-0.91	-0.83		-0.62	-0.92	0.97	0.82	-0.79	-0.79	-0.97
Common Stock Shares Outstanding	0.77	-0.27	0.89	0.88	0.69	-0.63	0.63	-0.79	0.85	-0.35	-0.71	0.9	0.09	-0.81	0.04	0.77	0.64	0.86	-0.62		0.7	-0.68	-0.93	0.89	0.34	0.71
Short Term Investments	0.99	0.24	0.66	0.76	0.91	-0.73	0.91	-0.86	0.74	0.09	-0.77	0.64	0.62	-0.86	0.21	0.69	0.99	0.75	-0.92	0.7		-0.9	-0.82	0.73	0.88	0.9
Non Current Liabilities Total	-0.94	-0.36	-0.79	-0.87	-1.0	0.9	-1.0	0.98	-0.88	-0.25	0.95	-0.6	-0.62	0.97	-0.5	-0.71	-0.9	-0.89	0.97	-0.68	-0.9		0.82	-0.84	-0.78	-1.0
Capital Lease Obligations	-0.86	0.18	-0.84	-0.9	-0.83	0.65	-0.79	0.88	-0.92	0.26	0.86	-0.93	-0.16	0.89	-0.23	-0.88	-0.76	-0.91	0.82	-0.93	-0.82	0.82		-0.92	-0.47	-0.85
Inventory	0.82	0.07	0.96	0.99	0.83	-0.79	0.8	-0.91	0.9	0.04	-0.89	0.86	0.19	-0.91	0.46	0.89	0.69	0.9	-0.79	0.89	0.73	-0.84	-0.92		0.41	0.85
Other Current Assets	0.84	0.53	0.38	0.47	0.8	-0.68	0.82	-0.67	0.47	0.35	-0.57	0.21	0.89	-0.67	0.16	0.31	0.93	0.5	-0.79	0.34	0.88	-0.78	-0.47	0.41		0.76
Other Stockholder Equity	0.94	0.29	0.79	0.87	1.0	-0.88	0.99	-0.99	0.91	0.18	-0.95	0.63	0.59	-0.98	0.49	0.72	0.9	0.92	-0.97	0.71	0.9	-1.0	-0.85	0.85	0.76

Click cells to compare fundamentals

Rxsight Account Relationship Matchups

Rxsight fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	100.7M	192.7M	150.2M	182.6M	209.9M	162.0M
Short Long Term Debt Total	30.8M	44.9M	45.0M	3.0M	3.5M	3.3M
Other Current Liab	9.2M	5.7M	9.4M	13.2M	15.2M	9.3M
Total Current Liabilities	11.6M	11.1M	17.2M	20.9M	24.0M	15.2M
Total Stockholder Equity	(297.5M)	138.2M	89.9M	160.4M	184.4M	193.6M
Property Plant And Equipment Net	18.6M	15.5M	14.1M	13.3M	12.0M	12.9M
Current Deferred Revenue	438K	618K	1.3M	2.0M	2.4M	2.5M
Net Debt	16.8M	20.6M	33.2M	(6.7M)	(7.7M)	(7.3M)
Retained Earnings	(430.6M)	(479.3M)	(546.0M)	(594.6M)	(535.2M)	(561.9M)
Accounts Payable	1.1M	1.7M	2.6M	3.9M	4.4M	2.5M
Cash	14.0M	24.4M	11.8M	9.7M	11.1M	14.9M
Non Current Assets Total	19.2M	16.4M	15.6M	14.1M	12.7M	13.7M
Non Currrent Assets Other	110K	114K	767K	147K	169.1K	274.8K
Cash And Short Term Investments	69.0M	159.3M	105.8M	127.2M	146.3M	119.2M
Net Receivables	2.9M	4.9M	11.0M	20.3M	23.3M	24.5M
Short Term Investments	55.0M	135.0M	94.0M	117.5M	135.1M	104.3M
Liabilities And Stockholders Equity	100.7M	192.7M	150.2M	182.6M	209.9M	162.0M
Non Current Liabilities Total	386.6M	43.4M	43.0M	1.3M	1.2M	1.1M
Capital Lease Obligations	6.4M	5.2M	4.8M	3.0M	2.7M	4.0M
Inventory	8.3M	8.0M	14.8M	17.4M	20.0M	12.3M
Other Current Assets	1.4M	8.1M	3.0M	3.5M	4.1M	3.9M
Other Stockholder Equity	(301.0M)	617.5M	636.0M	755.0M	868.2M	911.6M
Total Liab	398.2M	54.5M	60.3M	22.2M	20.0M	19.0M
Net Invested Capital	(273.1M)	178.0M	130.1M	160.4M	184.4M	193.6M
Property Plant And Equipment Gross	18.6M	15.5M	10.1M	36.0M	41.4M	21.9M
Total Current Assets	81.5M	176.3M	134.6M	168.4M	193.7M	143.2M
Accumulated Other Comprehensive Income	(3K)	(20K)	(95K)	(5K)	(4.5K)	(4.7K)
Capital Stock	80.8M	27K	28K	36K	32.4K	30.8K
Net Working Capital	69.9M	165.2M	117.3M	147.5M	169.6M	128.0M
Short Term Debt	1.3M	3.1M	3.9M	1.8M	2.1M	2.4M
Common Stock	80.8M	27K	28K	36K	32.4K	30.8K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC